Electrosurgical Power Control via Pulsed RF Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Electrosurgical procedures using RF energy often result in collateral tissue damage due to unintended delivery of power when the probe is not effectively treating tissue, leading to undesired cell death and excessive tissue removal.
Innovation Solution
Implementing a power control system that determines the operational parameter (impedance or temperature) of an electrosurgical probe and switches between constant and pulsed power modes based on predetermined ranges to ensure the probe operates within desired treatment parameters, limiting power delivery when not effectively treating tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If continuous high power is delivered to the probe, then effective tissue treatment (ablation, cutting, coagulation) is achieved, but collateral tissue damage and undesired cell death increase
Solution Approach 1:
The system implements periodic monitoring of probe parameters (impedance, temperature) and delivers power in controlled pulses rather than continuous delivery. When the probe is not effectively treating tissue, power is delivered in low-power intervals followed by high-power bursts only when treatment effectiveness is confirmed, thereby achieving effective tissue treatment while minimizing collateral damage during transition periods.
Solution Approach 2:
The system continuously monitors probe parameters (impedance, temperature) and uses this feedback to dynamically adjust power delivery. When parameters indicate effective tissue treatment, high power is delivered; when parameters fall outside predetermined ranges indicating ineffective treatment, power is reduced to low levels. This feedback mechanism ensures power is delivered only when needed, reducing collateral tissue damage while maintaining treatment effectiveness.
2Object-affected harmful factors
If power is limited when the probe is not treating tissue effectively, then collateral cell death is reduced, but delay in initiating effective treatment may occur
Solution Approach 1:
The system establishes predetermined parameter ranges for different probe designs before treatment begins. These preliminary settings allow the system to quickly determine whether the probe is effectively treating tissue without requiring extensive real-time analysis, thereby minimizing delay while ensuring power is only delivered at effective power levels when the probe is properly positioned and treating tissue.
Solution Approach 2:
The system dynamically adjusts power delivery based on real-time parameter monitoring. When the probe enters an effective treatment zone (parameters within predetermined ranges), power rapidly transitions from low to high levels. When the probe moves out of the effective zone, power transitions back to low levels. This dynamic adjustment minimizes both collateral damage and treatment delay by ensuring rapid response to probe position changes.
3Object-affected harmful factors
If parameter monitoring and power control algorithms are implemented, then power delivery is optimized and collateral damage is limited, but device complexity increases
Solution Approach 1:
The system uses the probe's own operational parameters (impedance, temperature) as indicators of treatment effectiveness. By monitoring parameters that naturally occur during probe operation, the system eliminates the need for additional sensors or complex external monitoring equipment. The predetermined parameter ranges are specific to each probe design, allowing the probe to essentially monitor itself and trigger appropriate power delivery adjustments without external intervention.
Solution Approach 2:
The system focuses on monitoring and controlling a limited set of critical parameters (impedance, temperature) rather than attempting to monitor all possible probe characteristics. By establishing predetermined ranges for these key parameters specific to each probe design, the system achieves effective power optimization with relatively simple monitoring and control logic, minimizing the increase in device complexity while still limiting collateral tissue necrosis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces collateral tissue necrosis and improves surgical outcomes by ensuring consistent and safe power delivery during electrosurgical procedures, minimizing unintended tissue damage.
Implementation Method 1
Radiofrequency (RF) energy is delivered to a surgical instrument, such as a probe, to treat diseased tissue, such as by ablating, shrinking, cutting, or coagulating the tissue
Implementation Method 2
that value of a parameter associated with operation of the probe (e.g., impedance or temperature) is determined and compared to a range of values for that parameter
Implementation Method 3
By limiting the power delivered when the probe is not treating tissue in the desired manner, the undesired surgical outcome is limited
Data Source
AI summary
A method and apparatus include determining a value of a parameter associated with operation of an electrosurgical probe having a particular probe design, and determining whether the value of the parameter is within a range of values that has been predetermined for the particular probe design to indicate that the probe is treating tissue in a desired manner. Power is delivered to the probe according to an algorithm based upon a determination that the value of the parameter is outside the range of values The algorithm delivers power in a pulsed profile including portions of low power and portions of high power. In one embodiment, the tissue treatment is ablation, the parameter is impedance, and the method limits tissue necrosis to less than 200 microns. In another embodiment, the tissue treatment is shrinkage, the parameter is temperature, and the method limits power delivery when the probe is not shrinking tissue.